Allarity Therapeutics will trade under new short name ALLR starting on 12 October 2020

NEXT STORY
ORIC Pharmaceuticals Announces Presentation of Preclinical Data on Glucocorticoid Receptor Antagonist Overcoming Resistance to an Androgen Receptor Degrader at the 32nd EORTC-NCI-AACR Symposium 2020
PREV STORY
Saniona receives pre-IND feedback from FDA on regulatory path for Tesomet in Prader-Willi Syndrome (PWS) and Hypothalamic Obesity (HO)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Influenza A Virus H7N9 Infection Drug Pipeline Study, H2 2018 – Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs

author_avatar
NASDAQ Market News

atai Life Sciences Increases Loan in Principal by US$6m to Support IntelGenx’s Graduation to Toronto Stock Exchange After Positive Early Feasibility Study Data

author_avatar
NASDAQ Market News

Antimicrobial Coatings Market Worth USD 7.36 Billion by 2025- Exclusive Report by Meticulous Research®

author_avatar
NASDAQ Market News